Raised plasma aldosterone and natriuretic peptides in atrial fibrillation

被引:53
作者
Dixen, Ulrik
Ravn, Lasse
Soeby-Rasmussen, Christian
Paulsen, Anders Wallin
Parner, Jan
Frandsen, Erik
Jensen, Gorm B.
机构
[1] Univ Hosp Gentofte, Dept Cardiol, DK-2900 Copenhagen, Denmark
[2] Danish Arrhythmia Res Ctr, Copenhagen, Denmark
[3] Univ Copenhagen, Glostrup Hosp, Dept Clin Physiol & Nucl Med, Copenhagen, Denmark
[4] Hvidovre Univ Hosp, Dept Cardiol, Copenhagen, Denmark
关键词
atrial fibrillation; aldosterone; natriuretic peptides; renin-angiotensin-aldosterone system;
D O I
10.1159/000095671
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Aims: During atrial fibrillation (AF), the renin-angiotensin- aldosterone system (RAAS) may be activated. In this study, our aim was to evaluate at a long-term followup visit the levels of plasma aldosterone and natriuretic peptides as markers of neurohormonal remodeling in patients with earlier, documented AF in relation to present heart rhythm, clinical data, and the left ventricular ejection fraction (LVEF). We hypothesized that increased levels of aldosterone and natriuretic peptides were significantly associated with present AF as markers of RAAS activation during the arrhythmia. Methods: We studied 158 patients with earlier ECG-documented AF followed by restored sinus rhythm (SR) attending a follow-up visit 2.6 years (mean) after primary inclusion. Results: At follow-up, 93 patients had SR. Heart rhythm at follow-up visit (SR/AF), plasma aldosterone, plasma N-terminal pro Brain Natriuretic Peptide (NtproBNP), plasma N-terminal pro Atrial Natriuretic Peptide (Nt-proANP), LVEF, medication, and clinical characteristics were recorded. Standard linear multiple regression analysis including age, sex, weight, hypertension, congestive heart failure, ischemic heart disease, present AF at follow-up, total duration of AF disease, ongoing medication, and the LVEF as explanatory variables showed that only ongoing treatment with diuretics was significantly associated ( likelihood ratio test, p = 0.0057) with a raised log-transformed plasma aldosterone, although present AF at follow-up was related to a high aldosterone level (p = 0.09). For the natriuretic peptides, present AF at follow-up (p < 0.0001), age (p < 0.0001), female gender (p = 0.0047), ischemic heart disease (p = 0.0154), and ongoing treatment with sotalol (p = 0.0003) were all independently associated with high log-transformed plasma Nt-proANP. Likewise, present AF at follow-up (p = 0.0008) as well as age (p < 0.0001) were associated with high log-transformed plasma Nt-proBNP. Conclusions: In patients with earlier AF, AF at long-term follow-up visit was independently associated with raised levels of Nt-proANP and Nt-proBNP and to some extent with plasma aldosterone indicating neurohormonal activation during arrhythmia. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 23 条
[1]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[2]   ANTIFIBROTIC EFFECTS OF SPIRONOLACTONE IN PREVENTING MYOCARDIAL FIBROSIS IN SYSTEMIC ARTERIAL-HYPERTENSION [J].
BRILLA, CG ;
MATSUBARA, LS ;
WEBER, KT .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (03) :A12-A16
[3]   NEUROHORMONAL CONSEQUENCES OF DIURETICS IN DIFFERENT CARDIOVASCULAR SYNDROMES [J].
BURNIER, M ;
BRUNNER, HR .
EUROPEAN HEART JOURNAL, 1992, 13 :28-33
[4]   Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting [J].
Dao, Q ;
Krishnaswamy, P ;
Kazanegra, R ;
Harrison, A ;
Amirnovin, R ;
Lenert, L ;
Clopton, P ;
Alberto, J ;
Hlavin, P ;
Maisel, AS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :379-385
[5]   Prolonged signal-averaged P wave duration after elective cardioversion increases the risk of recurrent atrial fibrillation [J].
Dixen, U ;
Joens, C ;
Parner, J ;
Rasmussen, V ;
Pehrson, SM ;
Jensen, GB .
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2004, 38 (03) :147-151
[6]   Rising rates of hospital admissions for atrial fibrillation [J].
Friberg, J ;
Buch, P ;
Scharling, H ;
Gadsboll, N ;
Jensen, GB .
EPIDEMIOLOGY, 2003, 14 (06) :666-672
[7]   Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation [J].
Goette, A ;
Hoffmanns, P ;
Enayati, W ;
Meltendorf, U ;
Geller, JC ;
Klein, HU .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (08) :906-+
[8]   A paradigm shift in treatment for atrial fibrillation:: from electrical to structural therapy? [J].
Heidbüchel, H .
EUROPEAN HEART JOURNAL, 2003, 24 (23) :2077-2078
[9]   Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study [J].
Jourdain, P ;
Bellorini, M ;
Funck, E ;
Fulla, Y ;
Guillard, N ;
Loiret, J ;
Thebault, B ;
Sadeg, N .
EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :263-267
[10]   Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates [J].
Kannel, WB ;
Wolf, PA ;
Benjamin, EJ ;
Levy, D .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (8A) :2N-8N